IPSIndian Journal of Pharmacology
Home  IPS  Feedback Subscribe Top cited articles Login 
Users Online : 1249 
Small font sizeDefault font sizeIncrease font size
Navigate Here
  »   My Preferences 
  »   Manuscript submission

 


This article has been cited by
1Side effects of methotrexate therapy for rheumatoid arthritis: A systematic review
Wanying Wang,Hua Zhou,Liang Liu
European Journal of Medicinal Chemistry.2018;158()502
[DOI]
2Side effects of methotrexate therapy for rheumatoid arthritis: A systematic review
François Willermain,Laure Caspers,Weber Celia,Dorine Makhoul
European Journal of Medicinal Chemistry.2019;158()502
[DOI]
3Treatment of severe non-infectious uveitis in high-risk conditions (Part 2): systemic infections; management and safety issues
Miguel Cordero-Coma,Raquel Salazar-Méndez,Taygan Yilmaz
Expert Opinion on Drug Safety.2015;14(9)1353
[DOI]
4Neuropsychiatric manifestations in rheumatoid arthritis
Andrei F. Joaquim,Simone Appenzeller
Autoimmunity Reviews.2015;14(12)1116
[DOI]
5Methotrexate
Andrei F. Joaquim,Simone Appenzeller
Reactions Weekly.2014;1483(1)66
[DOI]
6How do we manage and treat a patient with multiple sclerosis at risk of tuberculosis?
Yara Dadalti Fragoso,Tarso Adoni,Andrea Anacleto,Joseph Bruno Bidin Brooks,Margarete de Jesus Carvalho,Rinaldo Claudino,Alfredo Damasceno,Maria Lucia Brito Ferreira,Paulo Diniz da Gama,Marcus Vinicus Magno Goncalves,Anderson Kuntz Grzesiuk,Andre Palma da Cunha Matta,Monica Fiuza Koncke Parolin
Expert Review of Neurotherapeutics.2014;14(11)1251
[DOI]
7Risk of tuberculosis reactivation associated with traditional disease modifying anti-rheumatic drugs and non-anti-tumor necrosis factor biologics in patients with rheumatic disorders and suggestion for clinical practice
Fabrizio Cantini,Laura Niccoli,Alessandro Capone,Linda Petrone,Delia Goletti
Expert Opinion on Drug Safety.2019;18(5)415
[DOI]
Site Map | Home | Contact Us | Feedback | Copyright and Disclaimer
Online since 20th July '04
Published by Wolters Kluwer - Medknow